Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 27286 AL 27300

Mitochondrial Alterations, Oxidative Stress, and Therapeutic Implications in Alzheimer's Disease: A Narrative Review

Spina E, Ferrari RR, Pellegrini E, Colombo M, Poloni TE, Guaita A, Davin A.

Cells. 2025 Feb 6;14(3):229. doi: 10.3390/cells14030229.

The link between sarcopenic obesity and Alzheimer's disease: a brain-derived neurotrophic factor point of view

Copeland EN, LeBlanc PJ, Duarte-Guterman P, Fajardo VA, MacPherson REK.

J Physiol. 2026 Mar;604(6):2400-2410. doi: 10.1113/JP288032. Epub 2025 Feb 12.

Recent Insights on the Role of Nuclear Receptors in Alzheimer's Disease: Mechanisms and Therapeutic Application

Shan X, Li D, Yin H, Tao W, Zhou L, Gao Y, Xing C, Zhang C.

Int J Mol Sci. 2025 Jan 30;26(3):1207. doi: 10.3390/ijms26031207.

Myeloperoxidase as a therapeutic target for oxidative damage in Alzheimer's disease

Rivera Antonio AM, Padilla Martínez II, Torres-Ramos MA, Rosales-Hernández MC.

J Enzyme Inhib Med Chem. 2025 Dec;40(1):2456282. doi: 10.1080/14756366.2025.2456282. Epub 2025 Feb 14.

A Review on Nanotechnology based In Situ Gelling System as a Reliable Weapon for Targeting Alzheimer's Disease via Intranasal Route

Deorankar P, Minglani VV, Prajapati BG, Patel MB.

CNS Neurol Disord Drug Targets. 2025;24(8):594-609. doi: 10.2174/0118715273335978250127070434.

Beneficial and Detrimental Effects of Uric Acid on Alzheimer's Disease

Tovchiga O, Inkielewicz-Stepniak I.

Curr Neuropharmacol. 2025;23(12):1493-1517. doi: 10.2174/011570159X349365250128072146.

Hallmarks of aging and Alzheimer's Disease pathogenesis: Paving the route for new therapeutic targets

Bellelli F, Angioni D, Arosio B, Vellas B, De Souto Barreto P.

Ageing Res Rev. 2025 Apr;106:102699. doi: 10.1016/j.arr.2025.102699. Epub 2025 Feb 20.

Internet of Medical Things (IoMT) for Alzheimer Patient's Outcome

Lakshmipriya T, Gopinath SCB.

CNS Neurol Disord Drug Targets. 2025;24(7):491-493. doi: 10.2174/0118715273371149250218081425.

Presenilin, γ-Secretase, and the Search for Pathogenic Triggers of Alzheimer's Disease

Wolfe MS.

Biochemistry. 2025 Apr 15;64(8):1662-1672. doi: 10.1021/acs.biochem.4c00830. Epub 2025 Feb 25.

From Genetics to Neuroinflammation: The Impact of ApoE4 on Microglial Function in Alzheimer's Disease

Dias D, Portugal CC, Relvas J, Socodato R.

Cells. 2025 Feb 7;14(4):243. doi: 10.3390/cells14040243.

Immune Modulation in Alzheimer's Disease: From Pathogenesis to Immunotherapy

Balkhi S, Di Spirito A, Poggi A, Mortara L.

Cells. 2025 Feb 12;14(4):264. doi: 10.3390/cells14040264.

Phytomolecules as Alzheimer's therapeutics: A comprehensive review

Hussain MK, Ahmad M, Khatoon S, Khan MV, Azmi S, Arshad M, Ahamad S, Saquib M.

Eur J Med Chem. 2025 Apr 15;288:117401. doi: 10.1016/j.ejmech.2025.117401. Epub 2025 Feb 17.

The Potential Role of Phytochemicals in Alzheimer's Disease

Baranowska-Wójcik E, Gajowniczek-Ałasa D, Pawlikowska-Pawlęga B, Szwajgier D.

Nutrients. 2025 Feb 12;17(4):653. doi: 10.3390/nu17040653.

Innovations in noninvasive sensory stimulation treatments to combat Alzheimer's disease

Park JM, Tsai LH.

PLoS Biol. 2025 Feb 28;23(2):e3003046. doi: 10.1371/journal.pbio.3003046. eCollection 2025 Feb.

Antioxidants in anti-Alzheimer's disease drug discovery

Guo J, Zhu Y, Zhi J, Lou Q, Bai R, He Y.

Ageing Res Rev. 2025 May;107:102707. doi: 10.1016/j.arr.2025.102707. Epub 2025 Feb 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias